These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs. Ollerstam A; Visser SA; Duker G; Forsberg T; Persson AH; Nilsson LB; Björkman JA; Gabrielsson J; Al-Saffar A J Pharmacol Toxicol Methods; 2007; 56(2):131-44. PubMed ID: 17689270 [TBL] [Abstract][Full Text] [Related]
4. Methodological validation of an existing telemetry system for QT evaluation in conscious guinea pigs. Shiotani M; Harada T; Abe J; Hamada Y; Horii I J Pharmacol Toxicol Methods; 2007; 55(1):27-34. PubMed ID: 16831559 [TBL] [Abstract][Full Text] [Related]
5. Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes. Mitchell AZ; Bills AJ; Wittwer GT; Foley CM; Kremer JJ; Chen H; Osinski MA J Pharmacol Toxicol Methods; 2013; 68(1):62-73. PubMed ID: 23639348 [TBL] [Abstract][Full Text] [Related]
6. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants. Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820 [TBL] [Abstract][Full Text] [Related]
7. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment. Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685 [TBL] [Abstract][Full Text] [Related]
8. Isolated perfused and paced guinea pig heart to test for drug-induced changes of the QT interval. Cheng HC; Incardona J; McCullough B J Pharmacol Toxicol Methods; 2006; 54(3):278-87. PubMed ID: 16507347 [TBL] [Abstract][Full Text] [Related]
9. Practical application of guinea pig telemetry system for QT evaluation. Shiotani M; Harada T; Abe J; Sawada Y; Hashimoto K; Hamada Y; Horii I J Toxicol Sci; 2005 Aug; 30(3):239-47. PubMed ID: 16141657 [TBL] [Abstract][Full Text] [Related]
10. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model. Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000 [TBL] [Abstract][Full Text] [Related]
11. Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium. Holzgrefe H; Ferber G; Champeroux P; Gill M; Honda M; Greiter-Wilke A; Baird T; Meyer O; Saulnier M J Pharmacol Toxicol Methods; 2014; 69(1):61-101. PubMed ID: 23689033 [TBL] [Abstract][Full Text] [Related]
12. Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects. Hess P; Rey M; Wanner D; Steiner B; Clozel M Lab Anim; 2007 Oct; 41(4):470-80. PubMed ID: 17988441 [TBL] [Abstract][Full Text] [Related]
13. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499. Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323 [TBL] [Abstract][Full Text] [Related]
14. Calculation of QT shift in non clinical safety pharmacology studies. Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537 [TBL] [Abstract][Full Text] [Related]
15. Validation of the normal, freely moving Göttingen minipig for pharmacological safety testing. Markert M; Stubhan M; Mayer K; Trautmann T; Klumpp A; Schuler-Metz A; Schumacher K; Guth B J Pharmacol Toxicol Methods; 2009; 60(1):79-87. PubMed ID: 19427912 [TBL] [Abstract][Full Text] [Related]
16. Effects of group housing on ECG assessment in conscious cynomolgus monkeys. Xing G; Lu J; Hu M; Wang S; Zhao L; Zheng W; Schofield J; Oldman K; Adkins D; Yu H; Platz S; Ren J; Skinner M J Pharmacol Toxicol Methods; 2015; 75():44-51. PubMed ID: 25979821 [TBL] [Abstract][Full Text] [Related]
18. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts. Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345 [TBL] [Abstract][Full Text] [Related]
19. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs. Batey AJ; Doe CP J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037 [TBL] [Abstract][Full Text] [Related]
20. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation. Takahara A; Sugiyama A; Hashimoto K Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]